Bromocriptine is a synthetic ergot alkaloid that acts as a dopamine d2 receptor agonist. It is prescribed primarily to treat parkinson disease by supplementing deficient dopamine signaling in the brain. The drug also normalizes prolactin secretion making it useful for certain endocrine disorders. Its pharmacodynamic action involves stimulating dopamine receptors on neuronal and pituitary cells which reduces the release of prolactin and modulates motor pathways. By enhancing dopamine activity in the basal ganglia it improves tremor rigidity and bradykinesia associated with parkinson disease. In the pituitary dopamine receptor activation inhibits prolactin synthesis thereby lowering circulating prolactin levels. Overall the medication modulates several physiological processes including motor control and lactation through its active ingredient's interaction with dopamine signaling.

Bromocriptine is a dopamine receptor agonist that is used medically to treat conditions such as parkinson disease and hyperprolactinemia. Its therapeutic role is to stimulate dopamine receptors in the brain which helps restore normal dopaminergic activity. Pharmacologically it acts by binding to d2 receptors and partially to d3 and d4 receptors leading to decreased prolactin release and improved motor function. The drug activation of dopamine receptors modulates the secretion of prolactin from the pituitary gland and reduces the progression of certain neuroendocrine tumors. In the treatment of parkinson disease it enhances movement by compensating for the loss of dopaminergic neurons in the substantia nigra. Its pharmacokinetics involve oral absorption that is limited by first-pass metabolism and a long elimination half-life that allows once-daily dosing. Therapeutically it is prescribed to lower elevated prolactin levels in pituitary tumors and to manage symptoms of hormonal imbalances. The overall effect of Bromocriptine is to normalize hormonal balance and improve motor control through sustained stimulation of dopamine receptors.

Bromocriptine can cause nausea in some patients. Bromocriptine may lead to dizziness or lightheadedness. Bromocriptine sometimes results in headache or mild fever. Bromocriptine can produce constipation or abdominal discomfort. Bromocriptine occasionally lowers blood pressure leading to faintness. Bromocriptine may cause vomiting or loss of appetite. Bromocriptine sometimes results in fatigue or mild muscle pain.

Nausea may occur after taking Bromocriptine. Dizziness or light-headedness is also reported. Headaches are a frequent complaint. Some patients experience vomiting. Constipation can develop during treatment. Low blood pressure may cause fainting episodes. Fatigue or tiredness is commonly observed.